Eli Lilly to end 2024 among best in Big Pharma; Novo among worst
As the year draws to a close, Wall Street is set to crown Eli Lilly (NYSE:LLY) among the best in Big Pharma, while Novo ...
sciencenorway22h
A new medicine for almost everything – is it too good to be true?
Alzheimer's, addiction, cardiovascular diseases, kidney disorders, sleep apnoea, diabetes, obesity, and overweight.